Halo Collective (DB:A9K0) - Stock Price, News & Analysis

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

A9K0 Stock Overview

Engages in the cultivation, manufacture, transportation, and distribution of cannabis and cannabis extracts in Canada and the United States.

About the company

A9K0 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Rewards

Risk Analysis

Earnings have declined by 37.9% per year over past 5 years

Shareholders have been substantially diluted in the past year

Does not have a meaningful market cap (€2M)

Shares are highly illiquid

+ 1 more risk

Halo Collective Inc. Competitors

Biofrontera

XTRA:B8FK

€17.4m

Apontis Pharma

XTRA:APPH

€81.0m

Cantourage Group

XTRA:HIGH

€58.9m

Redx Pharma

DB:0RX

€65.0m

Price History & Performance

Summary of all time highs, changes and price drops for Halo Collective
Historical stock prices
Current Share Price	US$0.009
52 Week High	US$0.26
52 Week Low	US$0.009
Beta	1.75
11 Month Change	0%
3 Month Change	-25.00%
1 Year Change	-95.89%
33 Year Change	-100.00%
5 Year Change	n/a
Change since IPO	-100.00%

Recent updates

Shareholder Returns

	A9K0	DE Pharmaceuticals	DE Market
7D	0%	-1.8%	-1.8%
1Y	-95.9%	-12.8%	13.6%

Return vs Industry: A9K0 underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.

Return vs Market: A9K0 underperformed the German Market which returned 5.9% over the past year.

Price Volatility

Is A9K0's price volatile compared to industry and market?
A9K0 volatility
A9K0 Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	7.9%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	11.5%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: A9K0's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine A9K0's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2016	114	Katie Field	www.haloco.com

Halo Collective Inc., together with its subsidiaries, engages in the cultivation, manufacture, transportation, and distribution of cannabis and cannabis extracts in Canada and the United States. The company offers concentrates, such as shatter, sauce, live resin, badder, hash, rosin, and THC-A crystals; and oils in both in raw and distillated form in various strains and flavors, as well as strain specific cannabinoid ratios and blends. It also packages and sells cannabis derived terpene distillate vapor, botanical terpene, and live resin cartridges.

Halo Collective Inc. Fundamentals Summary

How do Halo Collective's earnings and revenue compare to its market cap?
A9K0 fundamental statistics
Market cap	€1.83m
Earnings (TTM)	-€67.44m
Revenue (TTM)	€17.12m

0.1x

P/S Ratio

0.0x

P/E Ratio

Is A9K0 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A9K0 income statement (TTM)
Revenue	US$18.30m
Cost of Revenue	US$13.02m
Gross Profit	US$5.27m
Other Expenses	US$77.33m
Earnings	-US$72.06m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.48
Gross Margin	28.83%
Net Profit Margin	-393.86%
Debt/Equity Ratio	59.1%

How did A9K0 perform over the long term?

See historical performance and comparison

This company listing is no longer active

A9K0 Stock Overview

Rewards

Risk Analysis

Halo Collective Inc. Competitors

XTRA:B8FK

€17.4m

XTRA:APPH

€81.0m

XTRA:HIGH

€58.9m

DB:0RX

€65.0m

Price History & Performance

Recent News & Updates

Halo Collective Inc. Announces Change to Board of Directors

Halo Collective Inc. Announces Expansion of Cannabis Genetics and Strain Portfolio, Specifically Within Its Oregon Operations

Halo Collective Inc., Annual General Meeting, Mar 24, 2023

Halo Collective Inc. announced that it has received $6.99999 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance, and other investors

Halo Collective Inc. Announces Launch of New Premium Cannabis Strains

High number of new and inexperienced directors

Recent updates

Halo Collective Inc. Announces Change to Board of Directors

Halo Collective Inc. Announces Expansion of Cannabis Genetics and Strain Portfolio, Specifically Within Its Oregon Operations

Halo Collective Inc., Annual General Meeting, Mar 24, 2023

Halo Collective Inc. announced that it has received $6.99999 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance, and other investors

Halo Collective Inc. Announces Launch of New Premium Cannabis Strains

High number of new and inexperienced directors

Halo Collective Inc. Appoints Katie Field as Chairman of the Board

Halo Collective Receives All Regulatory Approvals for Its Third Budega Dispensary in Hollywood, Halo's First Superstore

Halo Collective Inc. announced that it has received $6 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance and other investors

Halo Collective Inc. announced that it has received $5.999994 million in funding

Halo Collective Inc. Announces Management Changes

First quarter 2022 earnings released: US$0.28 loss per share (vs US$0.56 loss in 1Q 2021)

Halo Collective Inc. Announces Resignation of Philip Van Den Berg as Chief Financial Officer

Halo Collective Inc. Receives Final Approvals from the Los Angeles Department of Cannabis Regulation & California Department of Cannabis Control and the State Department of Cannabis Control

High number of new directors

Full year 2021 earnings released: US$4.12 loss per share (vs US$7.27 loss in FY 2020)

Less than half of directors are independent

Halo Collective Announces Changes to Board of Directors

Halo Collective Inc. Receives All Approvals for Budega™ Dispensary in North Hollywood, California

Halo Collective Inc. Receives All Approvals for Budega™ Dispensary in North Hollywood, California

Halo Collective Inc. (OTCPK:HCAN.F) completed the acquisition of 1285826 B.C. Ltd. from 1337617 B.C. Ltd., 1253540 B.C. Ltd. and NKG Investments Ltd.

Halo Collective Inc. announced that it expects to receive CAD 14 million in funding from Alpha Blue Ocean Investment Group

Halo Collective Receives Local Approvals for Budega™ Dispensary in Los Angeles's Noho Arts District

Halo Collective Inc. (OTCPK:HCAN.F) entered into an agreement to acquire 1285826 B.C. Ltd. for $7 million.

Third quarter 2021 earnings released: US$0.40 loss per share (vs US$0.42 loss in 3Q 2020)

High number of new directors

Halo Collective Inc. Announces the Official Launch of Ztrawberriez and 4 Prophets Premium Cannabis Flower

Halo Collective Inc. Announces FlowerShop, a Sensory-Care™ Brand Launches New Product Line, BUDVASE

Halo Collective Announces Reorganization of International Assets to Create Akanda

First quarter 2021 earnings released: US$0.006 loss per share (vs US$0.031 loss in 1Q 2020)

Halo Collective Inc. Provides Earnings Guidance for the Year 2021

Halo Collective Inc. Provides Sales Guidance for the Month Ended April 2021

Halo Collective Inc. announced that it expects to receive CAD 1 million in funding

Full year 2020 earnings released: US$0.073 loss per share (vs US$0.14 loss in FY 2019)

Halo Collective Inc. has completed a Composite Units Offering in the amount of CAD 10.000025 million.

PeakBirch Logic Inc. Announces Partnership with Halo Collective Inc. to Develop Functional Mushroom Line

Halo Collective Inc. Enters into Partnership with Nightingale Remedies (Nightingale) and PeakBirch Logic Inc

Halo Collective Inc. has completed a Composite Units Offering in the amount of CAD 8.00154 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 1275111 B.C. Ltd.

Halo Labs Inc. announced that it expects to receive CAD 2.25 million in funding

Chief Financial Officer recently sold €95k worth of stock

Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market

Third quarter 2020 earnings released: US$0.006 loss per share

Halo Labs Inc. Appoints Annmol Sidhu to the Board of Directors

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of CanMart Ltd from David Keith Dean and Darran William Quinn.

Fred Leigh Resigns to Halo Labs Inc.'s Board of Directors

Halo Labs Inc. (OTCPK:AGEE.F) entered into a binding Letter of Intent to acquire CanMart Ltd for CAD 4.6 million.

Halo Labs Inc. (OTCPK:AGEE.F) entered into an amended asset purchase agreement to acquire three operating KushBar retail cannabis stores from KushBar Inc. for CAD 3.4 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 1265292 B.C. Ltd.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of the remaining 85.28% stake in Ukiah Ventures Inc. from Odyssey Trust Company and others.

Earnings released

Halo Labs Inc. (OTCPK:AGEE.F) entered into a share exchange agreement to acquire the remaining 85.28% stake in Ukiah Ventures Inc. for $6.5 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 66.7% stake in LKJ11 LLC.

Halo Labs Inc. (OTCPK:AGEE.F) entered into a binding agreement to acquire a dispensary in Los Angeles.

Shareholder Returns

Price Volatility

About the Company

Halo Collective Inc. Fundamentals Summary